Anthony Loussouarn
Company: Chelatec
Job title: Chief Executive Officer
Seminars:
Chelatec – A Leading Preclinical CRO for Targeted Radionuclide Therapy 11:45 am
20 + years in the radiopharmaceutical space From radiolabeling to in vivo investigation The way to IND applicationRead more
day: P&T Track AM